We are pleased to announce that we now accept all major credit cards, as well as HSA and FSA for payment!
Hormones help regulate body temperature, sleep, mood, sexual health, bone strength, and many other functions. As hormone levels change during perimenopause and menopause, women may experience symptoms that affect their comfort, routines, relationships, and overall quality of life.
Bioidentical hormone replacement therapy, often called BHRT, uses hormones with the same chemical structure as hormones produced by the human body. For women, treatment may include estrogen and progesterone when hormone therapy is medically appropriate.
Optimal Female Wellness provides individualized hormone evaluations, treatment planning, medication management, and ongoing follow-up care. Hormone therapy is recommended only after reviewing symptoms, health history, treatment goals, potential benefits, and possible risks.
The term bioidentical describes the chemical structure of a hormone. It means the hormone in a medication is chemically identical to a hormone the body naturally produces.
However, bioidentical does not automatically mean natural, risk-free, safer, or more effective. The term also does not tell you whether a medication is FDA-approved or prepared by a compounding pharmacy.
Several FDA-approved estrogen and progesterone medications contain bioidentical hormones. These medications are available in standardized doses and have undergone FDA review for safety, effectiveness, quality, and manufacturing consistency.
Compounding pharmacies can also prepare customized hormone products when an FDA-approved option cannot meet a specific clinical need. Compounded medications do not undergo the same FDA premarket review as approved medications.
Patients should understand which type of medication is being prescribed, why it has been recommended, how it should be used, and what monitoring may be needed.
Women may consider hormone therapy when symptoms such as hot flashes, night sweats, vaginal dryness, painful intimacy, or sleep disruption begin to interfere with everyday life.
Perimenopause is the transitional period leading up to menopause. During this time, estrogen and progesterone levels can fluctuate unpredictably. Symptoms may appear even when menstrual periods are still occurring.
Menopause is generally identified after a woman has gone 12 consecutive months without a menstrual period, provided there is no other medical explanation.
Systemic estrogen therapy circulates throughout the body and may be considered for symptoms such as frequent hot flashes and night sweats. It is available in several forms, including tablets, skin patches, gels, and sprays.
Women who still have a uterus generally need a progestogen along with systemic estrogen. This helps protect the uterine lining from excessive growth that can occur when estrogen is used alone.
The type of medication, dose, delivery method, and treatment schedule depend on the woman’s symptoms, menstrual status, medical history, preferences, and individual risk factors.
Some women mainly experience vaginal or urinary changes rather than whole-body menopause symptoms.
These concerns may include:
Low-dose vaginal estrogen may be considered when these are the primary concerns. This treatment is applied directly to the vaginal area and generally results in less whole-body hormone exposure than systemic estrogen therapy.
Local estrogen is available in forms such as creams, tablets, inserts, and rings. The most appropriate option depends on symptoms, preferences, medical history, and the ability to use the medication consistently.
Bioidentical hormone therapy is not appropriate for every woman.
Additional evaluation may be needed for women with:
A history of one of these concerns does not always mean that every type of hormone therapy is prohibited. It does mean that treatment requires careful review and may involve additional testing or coordination with another healthcare provider.
The route of treatment may also matter. Oral, transdermal, and local hormone products are absorbed differently and may have different considerations.
Treatment decisions should be based on expected benefits, possible risks, available alternatives, and the patient’s personal priorities.
Women often hear the terms bioidentical and compounded used as though they mean the same thing. They do not.
An FDA-approved hormone medication can be bioidentical. Examples include certain forms of estradiol and micronized progesterone.
Compounded hormones are prepared by a pharmacy for an individual patient. They may be appropriate when a patient needs a dosage form, strength, or ingredient combination that is not available in an approved product.
However, compounded medications do not undergo the same FDA review for safety, effectiveness, manufacturing quality, and dosing consistency as approved medications.
When discussing hormone options, women should know:
The choice should be based on clinical need rather than the assumption that compounded products are automatically more personalized or safer.
Follow-up is an essential part of bioidentical hormone therapy.
After treatment begins, the care plan may need to be adjusted based on:
Women should report unexpected or persistent side effects rather than waiting until their next routine appointment.
Any bleeding after menopause should be evaluated. It should not automatically be assumed to be a normal effect of hormone therapy.
Patients should not increase their dosage, combine hormone products, stop prescribed progesterone, or use medication prescribed for someone else without medical guidance.
The lowest effective dose and the appropriate duration of treatment depend on the individual. Hormone therapy should be reviewed periodically to determine whether it is still helping and whether the treatment plan remains appropriate.
Hormone changes can affect sleep, body temperature, sexual comfort, mood, and everyday well-being. Appropriate care requires more than matching a symptom with a prescription.
Optimal Female Wellness provides personalized hormone evaluations and ongoing treatment support for women experiencing perimenopause, menopause, and related concerns.
Schedule an appointment to discuss your symptoms, medical history, treatment goals, and whether bioidentical hormone therapy or another approach may be appropriate for you.
Bioidentical hormone replacement therapy uses hormones with the same chemical structure as hormones naturally produced by the body. For women, treatment may include forms of estrogen and progesterone.
BHRT may be a form of menopause hormone therapy when bioidentical estrogen or progesterone is used to manage appropriate menopause-related symptoms. Not every menopause hormone medication is compounded.
Not automatically. Safety depends on the hormone, dose, delivery method, product, treatment reason, and the patient’s health history. The word bioidentical does not guarantee that a medication is safer.
No. Several FDA-approved estrogen and progesterone medications contain bioidentical hormones. Compounded hormones are custom-prepared products that do not undergo the same FDA premarket review.
Hormone therapy may help with hot flashes, night sweats, vaginal dryness, painful intimacy, and certain menopause-related sleep concerns. The most appropriate treatment depends on the symptoms and the patient’s health history.
Not every woman needs routine hormone testing to identify typical perimenopause or menopause. Testing may be recommended when symptoms are unusual, another condition is suspected, or the results would affect treatment.
Hormone therapy is not considered a weight-loss treatment. It may improve certain menopause symptoms that affect sleep or activity, but women primarily concerned about weight may need a separate medical weight-management evaluation.
Women who have a uterus generally need a progestogen when using systemic estrogen. This helps protect the uterine lining. Women who have had a hysterectomy may have different treatment needs.
There is no single timeline that applies to every woman. Treatment should be reviewed periodically based on symptom relief, side effects, personal risk factors, health changes, and patient preferences.
Monitoring may include symptom reviews, bleeding patterns, blood pressure, breast health, medication side effects, and laboratory testing when appropriate. The treatment plan may be adjusted as symptoms and health needs change.